Moderna said its Covid-19 vaccine booster shot produced a 'robust' antibody response against the highly contagious delta variant.
said its Covid-19 vaccine booster shot produced a "robust" antibody response against the highly contagious delta variant, according to details of a study released Thursday with the company's second-quarter earnings report.
In slides that accompanied the earnings report Thursday, Moderna said it expects the variant will lead to an increase in breakthrough infections, which occur in vaccinated individuals. People in the U.S. are already finding ways to secure booster shots amid concerns about delta. Still, the World Health Organization on Wednesday called on wealthy nations to stop the distribution of Covid booster shots, citing vaccine inequity around the world.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Covid-19: Scotland to end most Covid rules and cabinet splits over travelFive things you need to know about the coronavirus pandemic this Tuesday evening.
Consulte Mais informação »
Covid-19: One more Covid-linked death and 1,040 new casesThe total number of Covid-19 vaccines administered in Northern Ireland is now 2,284,540.
Consulte Mais informação »
Pfizer, Moderna Raise Prices Of Covid-19 Coronavirus Vaccines For European UnionThe EU has now surpassed the U.S. in getting its population vaccinated. But will higher Covid-19 coronavirus vaccine prices derail this progress?
Consulte Mais informação »
Malaysia grants conditional approval for Moderna COVID-19 vaccineMalaysia's Health Ministry on Thursday said it has granted a conditional approval for the Moderna COVID-19 vaccine for emergency use.
Consulte Mais informação »
Moderna says its COVID-19 shot provides 93% immunity after six monthsModerna Inc.'s undefined said Thursday that its COVID-19 vaccine is 93% efficacious six months after the second dose as part of its second-quarter earnings...
Consulte Mais informação »
COVID-19 live updates: Moderna vaccine 93% effective against symptomatic disease after 6 monthsModerna says its COVID vaccine is 93% effective against symptomatic illness after six months (though this data collection ended before delta emerged in the U.S.).
Consulte Mais informação »